Publicaciones en las que colabora con MARÍA NIEVES CABRERA MARTÍN (59)

2024

  1. Correction to: Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography (EJNMMI Physics, (2024), 11, 1, (12), 10.1186/s40658-024-00618-2)

    EJNMMI Physics

  2. Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography

    EJNMMI Physics, Vol. 11, Núm. 1

2023

  1. Metabolic characterization of structural lung changes in patients with findings suggestive of incidental COVID-19 pneumonia on 18F-FDG PET/CT: Pathophysiological insights from multimodal images obtained during the pandemic

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 6, pp. 380-387

2022

  1. Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging

    Frontiers in Aging Neuroscience, Vol. 13

2021

  1. Assessment of extra-parenchymal lung involvement in asymptomatic cancer patients with COVID-19 pneumonia detected on 18F-FDG PET-CT studies

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 3, pp. 768-776

  2. Incidental 68Ga-DOTATOC PET/CT Uptake in Hemorrhagic Transformation of Stroke in a Patient With Cervical Paraganglioma

    Clinical nuclear medicine, Vol. 46, Núm. 12, pp. e565-e566

  3. Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia

    Journal of Alzheimer's disease : JAD, Vol. 84, Núm. 1, pp. 151-167

  4. Tuberculosis ganglionar en la tomografía por emisión de positrones/tomografía axial computarizada con 18f-fluordexosiglucosa, a propósito de un caso

    Anales de la Real Academia Nacional de Medicina, Núm. 138, pp. 183-185

  5. Validation technique and improvements introduced in a new dedicated brain positron emission tomograph (CareMiBrain)

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 4, pp. 239-248

2020

  1. Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months

    Multiple Sclerosis and Related Disorders, Vol. 39

  2. Amyloid Positron Emission Tomography in Multiple Sclerosis: Between Amyloid Deposition and Myelin Damage

    Annals of Neurology

  3. Teragnosis en medicina nuclear

    Anales de la Real Academia Nacional de Medicina, Núm. 137, pp. 54-59

2019

  1. Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer’s disease: clinical assessment and metabolic correlates

    Brain Imaging and Behavior, Vol. 13, Núm. 3, pp. 651-659

  2. Machine learning in the clinical and language characterisation of primary progressive aphasia variants

    Cortex, Vol. 119, pp. 312-323

2018

  1. Clustering analysis of FDG-Pet imaging in primary progressive aphasia

    Frontiers in Aging Neuroscience, Vol. 10, pp. 1-12

  2. Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 61, Núm. 1, pp. 103-111

  3. Contribución de las técnicas de medicina nuclear en sarcomas de partes blandas y de los huesos: PET-TC y PET-RM. Futuro del diagnóstico por imagen

    Revisiones en Cancer, Vol. 32, Núm. 1, pp. 48-55

  4. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease

    International Journal of Geriatric Psychiatry, Vol. 33, Núm. 1, pp. 141-150

  5. Fármacos de uso diagnóstico

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 931-942

2017

  1. Amyloid PET in pseudotumoral multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 15, pp. 15-17